Differences in clinical outcomes in keratitis due to fungus and bacteria

JAMA Ophthalmology

Volumn 131, Issue 8, 2013, Pages 1088-1089

  Prajna, N Venkatesh ^a   Srinivasan, Muthiah ^a   Lalitha, Prajna ^a   Krishnan, Tiruvengada ^a   Rajaraman, Revathi ^a   Ravindran, Meenakshi ^a   Mascarenhas, Jeena ^a   Oldenburg, Catherine E ^b   Ray, Kathryn J ^b   McLeod, Stephen D ^b   Acharya, Nisha R ^b   Lietman, Thomas M ^b,c  

^a ARAVIND EYE CARE SYSTEM   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL KERATITIS; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; CORNEA PERFORATION; EPITHELIZATION; HUMAN; KERATOMYCOSIS; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SCAR; VISUAL ACUITY;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CORNEAL PERFORATION; CORNEAL ULCER; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FUNGI; HUMANS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84881624441     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.1612     Document Type: Letter

References (5)

1. Wong TY, Ng TP, Fong KS, Tan DT. Risk factors and clinical outcomes between fungal and bacterial keratitis: A comparative study. CLAO J. 1997;23(4):275-281.
2. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128(6):672-678.
3. Srinivasan M, Mascarenhas J, Rajaraman R, et al Steroids for Corneal Ulcers Trial Group. The Steroids for Corneal Ulcers Trial: Study design and baseline characteristics. Arch Ophthalmol. 2012;130(2):151-157.
4. Srinivasan M, Mascarenhas J, Rajaraman R, et al Steroids for Corneal Ulcers Trial Group. Corticosteroids for bacterial keratitis: The Steroids for Corneal Ulcers Trial (SCUT). Arch Ophthalmol. 2012;130(2):143-150.
5. Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006;113(4):526-530.